Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G1 cyclins/cyclin‐dependent kinases and the phosphoinositide 3‐kinase/AKT signaling cascade

Increasing evidence suggests that PRMT5, a protein arginine methyltransferase, is involved in tumorigenesis. However, no systematic research has demonstrated the cell‐transforming activity of PRMT5. We investigated the involvement of PRMT5 in tumor formation. First, we showed that PRMT5 was associated with many human cancers, through statistical analysis of microarray data in the NCBI GEO database. Overexpression of ectopic PRMT5 per se or its specific shRNA enhanced or reduced cell growth under conditions of normal or low concentrations of serum, low cell density, and poor cell attachment. A stable clone that expressed exogenous PRMT5 formed tumors in nude mice, which demonstrated that PRMT5 is a potential oncoprotein. PRMT5 accelerated cell cycle progression through G1 phase and modulated regulators of G1; for example, it upregulated cyclin‐dependent kinase (CDK) 4, CDK6, and cyclins D1, D2 and E1, and inactivated retinoblastoma protein (Rb). Moreover, PRMT5 activated phosphoinositide 3‐kinase (PI3K)/AKT and suppressed c‐Jun N‐terminal kinase (JNK)/c‐Jun signaling cascades. However, only inhibition of PI3K activity, and not overexpression of JNK, blocked PRMT5‐induced cell proliferation. Further analysis of PRMT5 expression in 64 samples of human lung cancer tissues by microarray and western blot analysis revealed a tight association of PRMT5 with lung cancer. Knockdown of PRMT5 retarded cell growth of lung cancer cell lines A549 and H1299. In conclusion, to the best of our knowledge, we have characterized the cell‐transforming activity of PRMT5 and delineated its underlying mechanisms for the first time.

[1]  Matthew A Powers,et al.  Protein arginine methyltransferase 5 accelerates tumor growth by arginine methylation of the tumor suppressor programmed cell death 4. , 2011, Cancer research.

[2]  Y. G. Zheng,et al.  Histone H4 Acetylation Differentially Modulates Arginine Methylation by an in Cis Mechanism* , 2011, The Journal of Biological Chemistry.

[3]  D. Clapham,et al.  pICln Binds to a Mammalian Homolog of a Yeast Protein Involved in Regulation of Cell Morphology* , 1998, The Journal of Biological Chemistry.

[4]  Nam-Soon Kim,et al.  Identification of gastric cancer-related genes using a cDNA microarray containing novel expressed sequence tags expressed in gastric cancer cells. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  T. Noda,et al.  PRMT5, a Novel TRAIL Receptor-Binding Protein, Inhibits TRAIL-Induced Apoptosis via Nuclear Factor-κB Activation , 2009, Molecular Cancer Research.

[6]  Xinbin Chen,et al.  PRMT5 is required for cell-cycle progression and p53 tumor suppressor function , 2009, Nucleic acids research.

[7]  Paloma Mas,et al.  A methyl transferase links the circadian clock to the regulation of alternative splicing , 2010, Nature.

[8]  Won-Kyung Cho,et al.  PRMT5, Which Forms Distinct Homo-oligomers, Is a Member of the Protein-arginine Methyltransferase Family* , 2001, The Journal of Biological Chemistry.

[9]  M. Herlyn,et al.  Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase. , 2010, Cancer cell.

[10]  Qin M. Chen,et al.  Methylation of FEN1 suppresses nearby phosphorylation and facilitates PCNA binding , 2010, Nature chemical biology.

[11]  S. Bao,et al.  srGAP2 Arginine Methylation Regulates Cell Migration and Cell Spreading through Promoting Dimerization* , 2010, The Journal of Biological Chemistry.

[12]  D. Fremont,et al.  Oncogenic potential of the DNA replication licensing protein CDT1 , 2002, Oncogene.

[13]  T. Veenstra,et al.  Arginine Methylation by PRMT5 at a Naturally Occurring Mutation Site Is Critical for Liver Metabolic Regulation by Small Heterodimer Partner , 2011, Molecular and Cellular Biology.

[14]  Robert L Moritz,et al.  PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing , 2009, Nature Structural &Molecular Biology.

[15]  S. Bao,et al.  Methylation of Ribosomal Protein S10 by Protein-arginine Methyltransferase 5 Regulates Ribosome Biogenesis* , 2010, The Journal of Biological Chemistry.

[16]  Tyler E. Miller,et al.  Methylation of histone H3 and H4 by PRMT5 regulates ribosomal RNA gene transcription , 2009, Journal of cellular biochemistry.

[17]  Utz Fischer,et al.  Assisted RNP assembly: SMN and PRMT5 complexes cooperate in the formation of spliceosomal UsnRNPs , 2002, The EMBO journal.

[18]  J. Qin,et al.  PRMT5 regulates Golgi apparatus structure through methylation of the golgin GM130 , 2010, Cell Research.

[19]  T. Suda,et al.  A Germ Cell-specific Gene, Prmt5, Works in Somatic Cell Reprogramming , 2011, The Journal of Biological Chemistry.

[20]  Peng Cui,et al.  Arginine methylation mediated by the Arabidopsis homolog of PRMT5 is essential for proper pre-mRNA splicing , 2010, Proceedings of the National Academy of Sciences.

[21]  L. Looijenga,et al.  Expression of BLIMP1/PRMT5 and concurrent histone H2A/H4 arginine 3 dimethylation in fetal germ cells, CIS/IGCNU and germ cell tumors , 2008, BMC Developmental Biology.

[22]  M. Grever,et al.  Low levels of miR-92 b / 96 induce PRMT 5 translation and H 3 R 8 / H 4 R 3 methylation in mantle cell lymphoma , 2013 .

[23]  J. Zhai,et al.  Mutations in the Type II Protein Arginine Methyltransferase AtPRMT5 Result in Pleiotropic Developmental Defects in Arabidopsis1[C][OA] , 2007, Plant Physiology.

[24]  Xiaojiang Xu,et al.  Application of machine learning methods to histone methylation ChIP-Seq data reveals H4R3me2 globally represses gene expression , 2010, BMC Bioinformatics.

[25]  W. Tarn,et al.  The Exon Junction Complex Component Y14 Modulates the Activity of the Methylosome in Biogenesis of Spliceosomal Small Nuclear Ribonucleoproteins* , 2011, The Journal of Biological Chemistry.

[26]  T. Yamori,et al.  ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor identified using the JFCR39 drug discovery system , 2010, Acta Pharmacologica Sinica.

[27]  Shinichiro Wachi,et al.  Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues , 2005, Bioinform..

[28]  Sharmistha Pal,et al.  Human SWI/SNF-Associated PRMT5 Methylates Histone H3 Arginine 8 and Negatively Regulates Expression of ST7 and NM23 Tumor Suppressor Genes , 2004, Molecular and Cellular Biology.

[29]  Kathleen R. Cho,et al.  Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas. , 2006, Cancer research.

[30]  N. Sonenberg,et al.  Eukaryotic Translation Initiation Factor 4E Regulates Expression of Cyclin D1 at Transcriptional and Post-transcriptional Levels (*) , 1995, The Journal of Biological Chemistry.

[31]  C. R. McClung,et al.  Type II protein arginine methyltransferase 5 (PRMT5) is required for circadian period determination in Arabidopsis thaliana , 2010, Proceedings of the National Academy of Sciences.

[32]  Chang-Hai Tsai,et al.  Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation , 2011, Nature Cell Biology.

[33]  A. Deblasio,et al.  JAK2V617F-mediated phosphorylation of PRMT5 downregulates its methyltransferase activity and promotes myeloproliferation. , 2011, Cancer cell.

[34]  Chi-Ying F. Huang,et al.  Phosphorylation and Stabilization of HURP by Aurora-A: Implication of HURP as a Transforming Target of Aurora-A , 2005, Molecular and Cellular Biology.

[35]  B. Yoo,et al.  Posttranslational arginine methylation of lamin A/C during myoblast fusion. , 2011, Biochimica et biophysica acta.

[36]  Raffaele Fronza,et al.  Global alterations in mRNA polysomal recruitment in a cell model of colorectal cancer progression to metastasis. , 2006, Carcinogenesis.

[37]  Chonglin Yang,et al.  Caenorhabditis elegans Protein Arginine Methyltransferase PRMT-5 Negatively Regulates DNA Damage-Induced Apoptosis , 2009, PLoS genetics.

[38]  S. Woo,et al.  Methylation of eukaryotic elongation factor 2 induced by basic fibroblast growth factor via mitogen-activated protein kinase , 2011, Experimental & Molecular Medicine.

[39]  S. Pestka,et al.  Hsl7p, the yeast homologue of human JBP1, is a protein methyltransferase. , 2000, Biochemical and biophysical research communications.

[40]  Sharmistha Pal,et al.  The Protein Arginine Methyltransferase Prmt5 Is Required for Myogenesis because It Facilitates ATP-Dependent Chromatin Remodeling , 2006, Molecular and Cellular Biology.

[41]  Sharmistha Pal,et al.  Protein Arginine Methyltransferase 5 Suppresses the Transcription of the RB Family of Tumor Suppressors in Leukemia and Lymphoma Cells , 2008, Molecular and Cellular Biology.

[42]  S. Pestka,et al.  The Human Homologue of the Yeast Proteins Skb1 and Hsl7p Interacts with Jak Kinases and Contains Protein Methyltransferase Activity* , 1999, The Journal of Biological Chemistry.

[43]  H. Erdjument-Bromage,et al.  Bromodomain protein 7 interacts with PRMT5 and PRC2, and is involved in transcriptional repression of their target genes , 2011, Nucleic acids research.

[44]  Sharmistha Pal,et al.  Low levels of miR‐92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma , 2007, The EMBO journal.

[45]  Vincent Nègre,et al.  Negative regulation of transcription by the type II arginine methyltransferase PRMT5 , 2002, EMBO reports.

[46]  Shuichi Tsutsumi,et al.  Global gene expression analysis of gastric cancer by oligonucleotide microarrays. , 2002, Cancer research.

[47]  Mogens Kruhøffer,et al.  Gene Expression in the Urinary Bladder , 2004, Cancer Research.

[48]  T. Noda,et al.  PRMT 5 , a Novel TRAIL Receptor-Binding Protein , Inhibits TRAIL-Induced Apoptosis via Nuclear Factor-κ B Activation , 2009 .

[49]  M. Surani,et al.  Prmt5 is essential for early mouse development and acts in the cytoplasm to maintain ES cell pluripotency. , 2010, Genes & development.